Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Vantuming Biological Technology is a specialized biotechnology firm focused on the research, development, and production of peptide-based products and biochemical reagents. Based in Qingdao, China, the company provides a broad range of services including custom peptide synthesis, the manufacture of amino acid derivatives, and the production of pharmaceutical intermediates. Vantuming supports the global life sciences community by supplying high-purity materials essential for drug discovery, diagnostic development, and academic research. Their technical capabilities include large-scale peptide manufacturing and complex organic synthesis. The company operates as a contract research and manufacturing organization (CRMO) for various pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao WanTuMing.